Table 2.

In vitro susceptibilities of C. albicans isolates

PatientIsolateMIC (μg/ml) of:
FluconazoleaKetoconazoleaItraconazoleaFluconazoleKetoconazoleItraconazoleAmphotericin B
IC2310.0150.06251.60.050.050.63
IC3280.03120.1256.30.10.20.63
IC39320.1250.125250.20.40.63
IIC4510.0150.03120.80.0250.0250.63
IIC1820.0150.06250.4≤0.025≤0.0250.63
IIC4620.0150.06250.8≤0.0250.0250.63
IIIC330.250.0150.03120.2≤0.025≤0.0250.32
IIIC3420.0150.06251.60.050.050.32
IIIC26>1284>2>1006.3>250.16
IIIC82320.51250.40.40.63
IVC2710.0150.03120.4≤0.0250.050.63
IVC3780.03250.06256.30.10.050.63
IVC4012821501.60.80.63
VC430.250.0150.03120.2≤0.025≤0.0250.63
VC4864211000.40.40.63
VC561284>21001.60.80.63
  • a MICs reported by Sanglard et al. (27).